Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery
OncoHypnose
1 other identifier
interventional
284
1 country
2
Brief Summary
The aims of the study are to compare the recovering period between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery. Comparaison of pain ( different types of pain), consumption of pain killers ,anxiety and fatigue on day0,1, 8 after surgery and every. 3 months during the first 2 years of follow up. Comparisons are also performed in substudies defined by treatments modalités. Inflammatory parameters s ( CRP\_ C reactive protein, NLR- ( neutrophils to lymphocyte ratio) are measured on Day 0, 1, 8 and also salivary Immunoglobulins and different endocannabinoids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2017
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedStudy Start
First participant enrolled
November 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJune 24, 2021
June 1, 2021
2.1 years
October 19, 2017
June 21, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Number of the days spent at the hospital post-surgery between the three groups
The aim of the study is to compare the recovering period hospitalisation and the different side effects (pain, anxiety, fatigue and consumption of pain killers ) during the post opérative period ( day 0, 1, 8- and at each follow up visit) between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery
Day 0, 1, 8 and every 3 months for 2 years after surgery
Comparaison of inflammatory parameters measured on day 0,1,8: CRP ( c reactive protein) and NLR ( neutrophils to lymphocyte ratio)
Blood test performed
Day 0, 1, 8
Secondary Outcomes (1)
Substudy evaluation of salivary immunoglobulins and endocannabinoids among 50 patients (25 under general anesthesia and 25 under hypnosis sedation
Simples collected on Day 0, 1 and 8 for endocannabinoids and salivary simples collected on Day 0 and 8
Study Arms (3)
General anesthesia
PLACEBO COMPARATORPatients will undergo oncologic breast surgery on general anesthesia.
Hypnosis sedation
EXPERIMENTALPatients will undergo oncologic breast surgery on hypnosis sedation.
General anesthesia with preoperative session of hypnosis
EXPERIMENTALPatients interested in hypnosis but too anxious to have surgery while on hypnosis sedation will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation using technology of virtual reality
Interventions
Patients will undergo oncologic breast surgery on general anesthesia.
Patients will undergo oncologic breast surgery on hypnosis sedation.
Patients will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation.
Eligibility Criteria
You may qualify if:
- Patient over 18 years old
- Signed informed consent form
- Patient has to be in possession of her administrative laws and affiliated to the social security insurance.
- The patient must have a diagnosis of resectable breast cancer (in situ or invasive breast cancer). . Surgical procedure must include evaluation of the axillary area (sentinel lymph node biopsy and or axillary dissection)
You may not qualify if:
- Patient under 18 years old
- No signed informed consent form
- Patients who haven't her social security insurance and prisoners are not eligible.
- No evaluation of the axillary area.
- Breast cancer in men
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hôpital de Jolimont
Haine-Saint-Paul, Hainaut, 7100, Belgium
Cliniques Universitaires Saint-Luc
Brussels, 1200, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martine Berlière, MD, PhD
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2017
First Posted
November 6, 2017
Study Start
November 15, 2017
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
June 24, 2021
Record last verified: 2021-06